| Bioactivity | Darizmetinib is an inhibitor of mitogen-activated protein kinase kinase (MAP2K)[1][2]. |
| Name | Darizmetinib |
| CAS | 2369583-33-3 |
| Formula | C21H17F2N5O3S |
| Molar Mass | 457.45 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Praefke B, et al. Preparation of pyrazolopyridines as protein kinase MKK4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death: World Intellectual Property Organization, WO2019149738. 2019-08-08. [2]. WHO Drug Information-World Health Organization (WHO). |